|
17 Mar 2020 |
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
|
|
17 Mar 2020 |
Imfinzi confirmed a sustained overall survival benefit in final analysis of the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
|
|
17 Mar 2020 |
Novo Nordisk pauses the clinical trials investigating concizumab (anti-TFPI mAB) in haemophilia A and B with or without inhibitors
|
|
16 Mar 2020 |
GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome
|
|
16 Mar 2020 |
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
|
|
16 Mar 2020 |
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19
|
|
16 Mar 2020 |
Tetraphase Pharmaceuticals and AcelRx Pharmaceuticals Enter into Definitive Merger Agreement
|
|
16 Mar 2020 |
Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of Lupus Nephritis
|
|
16 Mar 2020 |
BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China
|
|
16 Mar 2020 |
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
|
|
15 Mar 2020 |
Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline
|
|
15 Mar 2020 |
Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development
|
|
13 Mar 2020 |
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
|
|
13 Mar 2020 |
Pluristem and Charité University of Medicine Berlin Join Forces Targeting Potential Treatment for Respiratory and Inflammatory Intratissue Complications Caused by COVID-19
|
|
13 Mar 2020 |
Medicago Announces Production of a Viable Vaccine Candidate for COVID-19
|
|
13 Mar 2020 |
FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections
|
|
13 Mar 2020 |
Artugen Therapeutics Announces First Patient Dosed with ART24, Artugen’s First Clinical Product Candidate for Prevention of Recurrence of Clostridium Difficile Infection
|
|
13 Mar 2020 |
Henlius Received Acceptance Notification for Clinical Trial Application from NMPA for its Denosumab Biosimilar HLX14
|
|
13 Mar 2020 |
AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
|
|
13 Mar 2020 |
UCB provides an update on Phase 2b padsevonil safety and efficacy study in epilepsy (ARISE)
|
